BackgroundCheck.run
Search For

Joseph G Joyce, 6826310 Rampart Blvd #503, Punta Gorda, FL 33983

Known as:
Joseph C Joyce Joe G Joyce Joyce Josephy
Related to:
Christopher E Joyce 44

Joseph Joyce Phones & Addresses

26310 Rampart Blvd #503, Punta Gorda, FL 33983   

Port Charlotte, FL   

Upper Darby, PA   

Sugar Land, TX   

Wayne, NJ   

Cedar Grove, NJ   

Rome, GA   

Goldsboro, NC   

Ottawa, OH   

Honolulu, HI   

Get Report
Control this profile

Mentions for Joseph G Joyce

Career records & work history

Lawyers & Attorneys

Joseph Joyce Photo 1

Joseph Joyce - Lawyer

Office:
Elliott Greenleaf
Specialties:
Appeals
ISLN:
918403672
Admitted:
2005
University:
University of Pittsburgh, B.A., 2002
Law School:
Roger Williams University School of Law, J.D., 2005

License Records

Joseph William Joyce

Licenses:
License #: 7602 - Expired
Issued Date: Apr 15, 1967
Renew Date: Dec 14, 1990
Expiration Date: Dec 14, 1990
Type: Professional Engineer

Joseph Joyce

Licenses:
License #: 34EI00861200 - Expired
Category: Electrical Contractors
Issued Date: Jan 9, 1986
Expiration Date: Mar 31, 1997
Type: Electrical Contractor

Joseph J Joyce

Licenses:
License #: RS041280A - Expired
Category: Real Estate Commission
Type: Real Estate Salesperson-Standard

Joseph Joyce

Licenses:
License #: 34EI00861200 - Expired
Category: Electrical Contractors
Issued Date: Jan 9, 1986
Expiration Date: Mar 31, 1997
Type: Electrical Contractor

Joseph Joyce resumes & CV records

Resumes

Joseph Joyce Photo 41

Joseph Joyce

Joseph Joyce Photo 42

Joseph Joyce

Joseph Joyce Photo 43

Joseph Joyce

Joseph Joyce Photo 44

Joseph Joyce

Joseph Joyce Photo 45

Joseph Joyce

Location:
United States
Joseph Joyce Photo 46

Joseph Joyce - Little Silver, NJ

Work:
Bedi Quantum, a division of Bedi Capital LLC Sep 2013 to 2000
Principal, Director of Trading JBNJ designs Trading Systems and Commodity Market Indicators Sep 2005 to 2000 President, Risk Manager, Compliance Manager AdAlta Trading LLC. a prop trading firm Oct 2011 to Mar 2013 HTG Capital Management Nov 2010 to Sep 2011
Proprietary Trader SeaQuest Capital Management LLC May 2000 to Sep 2005
President, Director of Research, Head Trader, Principal SunQuest Trading Advisory Group and SGI International Inc Mar 1995 to Apr 2000
Director of Trading Member New York Futures Exchange - New York, NY Jan 1990 to Dec 1993
Pit Trader for Personal Account Henderson Brothers Futures Corp Jan 1989 to Jan 1990
President Member New York Futures Exchange May 1986 to Jan 1989 ACLI International Aug 1982 to Mar 1986
Vice President Donaldson Lufkin Jenrette Futures Corp local trader Sep 1980 to Jun 1982
Member Chicago Mercantile Exchange. Pit Trader Sylvester Racing Stables May 1979 to Dec 1980
Assistant Trainer Western Trading Co Aug 1979 to Sep 1980
Runner, phone clerk, out-trade clerk
Education:
Fairfield University Sep 1975 to May 1979
B.A. in Economics
Joseph Joyce Photo 47

Joseph Joyce

Work:
Sony Music DADC - Pitman, NJ Jul 2008 to Feb 2009
Machine Operator Pitman Warehousing - Pitman, NJ Sep 2004 to Jun 2005
Education:
Academy of Computer Careers - Jersey, UK Mar 2003
computers Clayton High School - Jersey, UK Jun 1999
diploma in mathematics

Publications & IP owners

Wikipedia

Joseph Joyce Photo 50

Joseph Joyce

Joseph "Joe" Joyce (born 19 September 1985 in London) is an amateur boxer from England. He competed in the men's super heavyweight division at the 2014 ...

Us Patents

Dna Encoding Human Papilloma Virus Type 18

US Patent:
6908615, Jun 21, 2005
Filed:
Mar 18, 1996
Appl. No.:
08/913644
Inventors:
Kathryn J. Hofmann - Collegeville PA, US
Kathrin U. Jansen - Fort Washington PA, US
Michael P. Neeper - Collegeville PA, US
Joseph G. Joyce - Lansdale PA, US
Hugh A. George - Schwenksville PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K039/12
US Classification:
4242041, 4241861, 4353201, 435 6, 435 691, 4352351, 530300
Abstract:
The present invention is directed to DNA molecules encoding purified human papillomavirus type 18 and derivatives thereof.

Protein Delivery System Using Human Papillomavirus Virus-Like Particles

US Patent:
6991795, Jan 31, 2006
Filed:
Aug 10, 1999
Appl. No.:
09/762794
Inventors:
Robert S. Lowe - North Wales PA, US
Kathrin U. Jansen - Doylestown PA, US
Joseph G. Joyce - Lansdale PA, US
William L. McClements - Doylestown PA, US
Jessica Ching-Yee Ling - Bensalem PA, US
Michael P. Neeper - Collegeville PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C12N 7/04
C07K 14/025
A61K 39/12
US Classification:
4241851, 4241861, 4241921, 4242041, 435455, 435456, 4353201, 435325, 435366, 435371, 536 231, 536 2372, 514 2
Abstract:
Human Papillomavirus virus like particles (VLPs) have been constructed so that they contain a modified L2 protein. The L2 protein has been minimized and is fused to a second protein or peptide. The fused protein is incorporated into the VLP and the VLP can deliver the protein to a cell. The modified VLPs can be used to increase the breadth of immune response in vaccine preparations or to deliver other proteins of interest.

Peptide Conjugate Compositions And Methods For The Prevention And Treatment Of Alzheimer's Disease

US Patent:
7850973, Dec 14, 2010
Filed:
May 1, 2006
Appl. No.:
11/919897
Inventors:
Victor M. Garsky - Blue Bell PA, US
Joseph G. Joyce - Lansdale PA, US
Paul M. Keller - Lansdale PA, US
Gene Kinney - Collegeville PA, US
Xiaoping Liang - Collegeville PA, US
John W. Shiver - Doylestown PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 39/00
A61K 39/08
A61K 39/095
A61K 39/02
A61K 38/08
A61K 45/00
A61K 33/06
US Classification:
4241851, 42419711, 4242361, 4242471, 4242501, 4241821, 424682, 424698, 4242781, 4242821, 4242831
Abstract:
The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of Aβ, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to Aβ. In another aspect, the immunogenic fragment of Aβ is capable of elevating plasma Aβ levels. The immunogenic fragments comprise linear or multivalent peptides of Aβ. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant.

Anthrax Vaccine

US Patent:
2007014, Jun 28, 2007
Filed:
Jul 30, 2004
Appl. No.:
10/566088
Inventors:
Michael Caulfield - Rahway NJ, US
James Cook - Lansdale PA, US
Joseph Joyce - Lansdale PA, US
Assignee:
MERCK & CO., INC. - Rahway NJ
International Classification:
A61K 39/295
A61K 39/116
A61K 39/095
C07K 14/22
US Classification:
424201100, 424203100, 424250100, 530350000
Abstract:
This invention provides a conjugate between poly-D-gamma glutamic acid and a carrier protein. The conjugate can be used for therapeutic or prophylactic immunization against anthrax infections. The invention also includes methods of purifying poly-D-gamma glutamic acid, methods of conjugation, vaccines and methods of vaccination against .

High Throughput Protein Interaction Assay

US Patent:
2011001, Jan 20, 2011
Filed:
Mar 17, 2009
Appl. No.:
12/921890
Inventors:
Michael J. Caulfield - West Point PA, US
Michael D. Miller - Chalfont PA, US
Joseph G. Joyce - Lansdale PA, US
Paul D. Zuck - Trenton NJ, US
Krista L. Getty - Quakertown PA, US
Vadim Dudkin - Lansdale PA, US
Elizabeth A. Ottinger - Harleysville PA, US
International Classification:
A61K 39/385
C40B 30/04
A61K 39/21
A61K 39/29
A61K 39/095
A61K 39/00
C07D 401/12
C07D 211/60
A61P 37/04
A61P 31/18
A61P 31/14
A61P 31/04
A61P 37/02
A61P 29/00
A61P 3/10
A61P 25/00
US Classification:
42419611, 506 9, 4242081, 4242281, 4242501, 42419711, 4241841, 544365, 546189, 546208, 546225
Abstract:
A method to identify small molecules useful as therapeutics and/or vaccines to prevent, alleviate or ameliorate a pathogenic infection or an autoimmune disorder. The method can be used to screen small molecule test compounds for the ability to disrupt particular antigen-antibody interactions of interest. In one embodiment, the antigen is a pathogen-derived antigen and the antibody decreases or inhibits virulence of the pathogen when bound to the antigen (e.g., a neutralizing antibody, antibody with serum bactericidal activity, etc.). In another embodiment, the antigen is a self-antigen (autoantigen) and the antibody is an autoantibody that is known to be associated with a pathological condition (e.g., autoimmune disorder). Compounds that bind to the antigen or antibody disrupt binding can be used as therapeutics to decrease or inhibit the autoimmune disorder.

Peptide Conjugate Compositions And Methods For The Prevention And Treatment Of Alzheimer's Disease

US Patent:
2011005, Mar 3, 2011
Filed:
Nov 8, 2010
Appl. No.:
12/907493
Inventors:
VICTOR M. GARSKY - BLUE BELL PA, US
JOSEPH G. JOYCE - LANSDALE PA, US
PAUL M. KELLER - LANSDALE PA, US
GENE KINNEY - BURLINGAME CA, US
XIAOPING LIANG - COLLEGEVILLE PA, US
JOHN W. SHIVER - DOYLESTOWN PA, US
International Classification:
A61K 39/00
A61K 39/395
A61P 25/28
A61P 25/00
US Classification:
4241781, 4241851
Abstract:
The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of Aβ, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to Aβ. In another aspect, the immunogenic fragment of Aβ is capable of elevating plasma Aβ levels. The immunogenic fragments comprise linear or multivalent peptides of Aβ. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant.

Recombinant Human Papillomavirus Type 18 Vaccine

US Patent:
5820870, Oct 13, 1998
Filed:
Mar 22, 1995
Appl. No.:
8/409122
Inventors:
Joseph G. Joyce - Lansdale PA
Hugh A. George - Schwenksville PA
Kathryn J. Hofman - Collegeville PA
Kathrin U. Jansen - Ft. Washington PA
Michael P. Neeper - Collegeville PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3902
A61K 3900
C12P 2106
C07K 100
US Classification:
4242041
Abstract:
The present invention is directed to vaccines for human papillomavirus type 18 and derivatives thereof.

Synthetic Hpv6/11 Hybrid L1 Dna Encoding Human Papillomavirus Type 11 L1 Protein

US Patent:
6159729, Dec 12, 2000
Filed:
Jan 26, 1998
Appl. No.:
8/913462
Inventors:
Kathryn J. Hofmann - Collegeville PA
Kathrin U. Jansen - Fort Washington PA
Michael P. Neeper - Collegeville PA
Joseph G. Joyce - Lansdale PA
Hugh A. George - Schwenksville PA
E. Dale Lehman - Lansdale PA
Assignee:
Merck & Co., Ltd. - Rahway NJ
International Classification:
C12N 1511
C12N 1581
US Classification:
4353201
Abstract:
The present invention is directed to a synthetic DNA molecule encoding purified human papillomavirus type 11 L1 protein and derivatives thereof.

Isbn (Books And Publications)

The Economic Activities Of Business: An Analysis Of The Modern Corporation

Author:
Joseph P. Joyce
ISBN #:
0275923169

Possible Relatives

David K Joyce  Deanna L Joyce  Deborah L Joyce  Danelle S Joyce  Debra A Joyce  Daniel J Joyce  Aaron H Joyce  Joseph J Johnson  Joseph D Stamps  Joseph N Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.